Use of granulocyte colony-stimulating factor plus plerixafor for stem cell mobilization is cost-effective in pretreated patients with non-Hodgkin lymphoma.
Martin Gregory, BA
Advertisement
Articles by Martin Gregory, BA
Advertisement
Latest Updated Articles
- Economic Evaluation of Plerixafor for Stem Cell Mobilization
Published: January 19th 2012 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Trump Administration Flags Potential Link Between Prenatal Acetaminophen Use, Autism
2
Childhood Cancer Awareness Month Spotlights Barriers That Persist in Care
3
Nicotinamide Reduces New Skin Cancer Risk in Large Veteran Study
4
More Effective CKD Strategy Could Have Health, Societal Benefits
5
